Mather Group LLC. Acquires 37,037 Shares of Kenvue Inc. $KVUE

Mather Group LLC. raised its holdings in shares of Kenvue Inc. (NYSE:KVUE) by 122.8% during the fourth quarter, according to its most recent filing with the SEC. The firm owned 67,206 shares of the company’s stock after purchasing an additional 37,037 shares during the period. Mather Group LLC.’s holdings in Kenvue were worth $1,159,000 at the end of the most recent reporting period.

Several other large investors have also modified their holdings of KVUE. Salomon & Ludwin LLC purchased a new stake in shares of Kenvue in the 3rd quarter worth approximately $25,000. NBT Bank N A NY increased its holdings in Kenvue by 180.3% during the third quarter. NBT Bank N A NY now owns 1,564 shares of the company’s stock valued at $25,000 after buying an additional 1,006 shares during the period. Cornerstone Planning Group LLC increased its holdings in Kenvue by 705.2% during the third quarter. Cornerstone Planning Group LLC now owns 1,554 shares of the company’s stock valued at $25,000 after buying an additional 1,361 shares during the period. Golden State Wealth Management LLC raised its stake in Kenvue by 150.1% in the third quarter. Golden State Wealth Management LLC now owns 1,983 shares of the company’s stock worth $32,000 after buying an additional 1,190 shares in the last quarter. Finally, Trust Co. of Vermont raised its stake in Kenvue by 50.9% in the third quarter. Trust Co. of Vermont now owns 2,385 shares of the company’s stock worth $39,000 after buying an additional 804 shares in the last quarter. Institutional investors own 97.64% of the company’s stock.

Kenvue Price Performance

Shares of KVUE opened at $17.52 on Friday. The company has a 50 day moving average of $18.01 and a two-hundred day moving average of $17.14. The company has a quick ratio of 0.68, a current ratio of 0.96 and a debt-to-equity ratio of 0.66. Kenvue Inc. has a twelve month low of $14.02 and a twelve month high of $25.17. The company has a market cap of $33.57 billion, a price-to-earnings ratio of 22.75, a price-to-earnings-growth ratio of 3.99 and a beta of 0.51.

Kenvue (NYSE:KVUE) last issued its quarterly earnings results on Tuesday, February 17th. The company reported $0.27 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.22 by $0.05. Kenvue had a return on equity of 19.72% and a net margin of 9.72%.The business had revenue of $3.78 billion for the quarter, compared to the consensus estimate of $3.68 billion. During the same period in the prior year, the firm posted $0.26 earnings per share. The business’s quarterly revenue was up 3.2% on a year-over-year basis. As a group, analysts predict that Kenvue Inc. will post 1.14 earnings per share for the current fiscal year.

Kenvue Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Wednesday, February 25th. Investors of record on Wednesday, February 11th were given a dividend of $0.2075 per share. This represents a $0.83 annualized dividend and a yield of 4.7%. The ex-dividend date of this dividend was Wednesday, February 11th. Kenvue’s dividend payout ratio is currently 107.79%.

Analyst Ratings Changes

KVUE has been the topic of several recent research reports. Argus raised Kenvue to a “hold” rating in a research report on Friday, March 6th. Jefferies Financial Group lowered Kenvue from a “buy” rating to a “hold” rating and reduced their price target for the stock from $23.00 to $18.00 in a research report on Friday, January 30th. Canaccord Genuity Group upped their price objective on Kenvue from $17.00 to $18.00 and gave the stock a “hold” rating in a research note on Wednesday, February 18th. Barclays raised their price objective on Kenvue from $18.00 to $19.00 and gave the company an “equal weight” rating in a research report on Friday, March 6th. Finally, UBS Group lifted their target price on Kenvue from $17.00 to $19.00 and gave the company a “neutral” rating in a research note on Wednesday, February 18th. Three research analysts have rated the stock with a Buy rating and thirteen have issued a Hold rating to the company. According to data from MarketBeat, Kenvue currently has an average rating of “Hold” and an average price target of $19.58.

Kenvue Company Profile

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.